首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   4633篇
  免费   243篇
  国内免费   19篇
电工技术   72篇
综合类   6篇
化学工业   1207篇
金属工艺   106篇
机械仪表   75篇
建筑科学   188篇
矿业工程   5篇
能源动力   152篇
轻工业   365篇
水利工程   21篇
石油天然气   16篇
武器工业   1篇
无线电   567篇
一般工业技术   838篇
冶金工业   410篇
原子能技术   32篇
自动化技术   834篇
  2023年   27篇
  2022年   77篇
  2021年   87篇
  2020年   73篇
  2019年   85篇
  2018年   118篇
  2017年   104篇
  2016年   129篇
  2015年   113篇
  2014年   167篇
  2013年   289篇
  2012年   236篇
  2011年   301篇
  2010年   231篇
  2009年   195篇
  2008年   242篇
  2007年   220篇
  2006年   196篇
  2005年   164篇
  2004年   143篇
  2003年   126篇
  2002年   132篇
  2001年   63篇
  2000年   74篇
  1999年   70篇
  1998年   98篇
  1997年   98篇
  1996年   83篇
  1995年   75篇
  1994年   66篇
  1993年   49篇
  1992年   43篇
  1991年   38篇
  1990年   51篇
  1989年   44篇
  1988年   27篇
  1987年   26篇
  1986年   24篇
  1985年   41篇
  1984年   42篇
  1983年   38篇
  1982年   44篇
  1981年   33篇
  1980年   18篇
  1979年   29篇
  1978年   21篇
  1977年   22篇
  1976年   24篇
  1974年   15篇
  1970年   15篇
排序方式: 共有4895条查询结果,搜索用时 15 毫秒
31.
32.
33.
Tamoxifen (TAM), the only antiestrogen currently available for the endocrine therapy of breast cancer behaves as a mixed agonist/antagonist of estrogen action, thus limiting its therapeutic potential. We report the binding characteristics of a novel series of nonsteroidal antiestrogens to the rat uterine estrogen receptor. As measured by competition studies, the affinity of EM-652, the active metabolite of the prodrug EM-800, for the estrogen receptor is 7-11 times higher than that of 17beta-estradiol (E2), ICI 182780, and hydroxy-tamoxifen (OH-TAM), the active metabolite of Tamoxifen. EM-652 is 20x more potent than ICI 164384 and Droloxifene while it is 400 times more potent than Toremifene in displacing [3H]E2 from the rat uterine estrogen receptor. On the other hand, the prodrug EM-800 and Tamoxifen have respectively 150-fold and 410-fold less affinity for the estrogen receptor than the pure antiestrogen EM-652. No significant binding of EM-652, EM-800, TAM or OH-TAM was observed to the rat uterine progesterone receptor at concentrations up to 10,000 nM except for TAM that caused a 50% displacement of labeled R5020 at 4000 nM. No significant binding of EM-652 or EM-800 was observed on the rat ventral prostate androgen receptor or the rat uterine progesterone receptor. The present data demonstrate the high affinity and specificity of the new antiestrogen, EM-652, for the rat uterine estrogen receptor. The antiestrogen EM-652 thus becomes the compound having the highest known affinity for the estrogen receptor. Due to its unique potency and its pure antiestrogenic activity already demonstrated in many systems, this antiestrogen could well offer an important advance for the endocrine therapy of breast cancer, uterine cancer, and other estrogen-sensitive diseases in women.  相似文献   
34.
BACKGROUND: The objective of this study was to evaluate the prevalence of osteoporosis and osteopenia in Czech women and men aged 50 to 75 years. METHODS AND RESULTS: Bone mineral density was assessed in an age-stratified random sample of 713 women and 429 men from two cities (Prague and Litom?rice) in the lumbar spine, proximal femur and total body by dual X-ray absorptiometry and in the distal forearm by single X-ray absorptiometry. The proportion of women and men in each age group with bone density below specified levels at any of these skeletal sites was projected to the population structure of the Czech Republic. With advancing age, in women at 55 years and in men at 65 years of age the population with normal bone mineral density becomes smaller, and a greater proportion has osteopenia or osteoporosis. Overall, an estimated 428,000 women and 195,000 men over age 50 have osteoporosis and another 680,000 women and 435,000 men have osteopenia. CONCLUSIONS: The results of this first population-based cross sectional study in the Czech Republic document a high prevalence of osteoporosis and osteopenia which is comparable with that published for the Netherlands and the United States. The results offer a basis for economical considerations in diagnosis, treatment and consequences of osteoporosis.  相似文献   
35.
An analysis is given of the performance of the standard forgetting factor recursive least squares (RLS) algorithm when used for tracking time-varying linear regression models. Three basic results are obtained: (1) the ‘P-matrix’ in the algorithm remains bounded if and only if the (time-varying) covariance matrix of the regressors is uniformly non-singular; (2) if so, the parameter tracking error covariance matrix is of the order O(μ + γ2/μ), where μ = 1 - λ, λ is the forgetting factor and γ is a quantity reflecting the speed of the parameter variations; (3) this covariance matrix can be arbitrarily well approximated (for small enough μ) by an expression that is easy to compute.  相似文献   
36.
In this paper,an adaptive control scheme is introduced for permanent magnet synchronous machines (PMSMs)as an alternative to classical control techniques.The adaptive control strategy capitalizes on the machine’s inverse dynamics to achieve accurate tracking by using an observer to approximate disturbance in the form of friction and load torque.The controller’s output is then fed to a space vector pulse width modulation(SVPWM)algorithm to produce duty cycles for the inverter.The control scheme is validated through a set of simulations on an experimentally validated PMSM model.Results for different situations highlight its high speed tracking accuracy and high performance in compensating for friction and load disturbances of various magnitudes.  相似文献   
37.
EASEA is a framework designed to help non-expert programmers to optimize their problems by evolutionary computation. It allows to generate code targeted for standard CPU architectures, GPGPU-equipped machines as well as distributed memory clusters. In this paper, EASEA is presented by its underlying algorithms and by some example problems. Achievable speedups are also shown onto different NVIDIA GPGPUs cards for different optimization algorithm families.  相似文献   
38.
The influence of hyperhomocysteinemia (HHCy) on cardiovascular disease (CVD) remains unclear. HHCy is associated with inflammation and atherosclerosis, and it is an independent risk factor for CVD, stroke and myocardial infarction. However, homocysteine (HCy)-lowering therapy does not affect the inflammatory state of CVD patients, and it has little influence on cardiovascular risk. The HCy degradation product hydrogen sulfide (H2S) is a cardioprotector. Previous research proposed a positive role of H2S in the cardiovascular system, and we discuss some recent data suggesting that HHCy worsens CVD by increasing the production of H2S, which decreases the expression of adenosine A2A receptors on the surface of immune and cardiovascular cells to cause inflammation and ischemia, respectively.  相似文献   
39.
The oxidation behavior of HfC, HfC-25 wt. % TaC, and HfC-7 wt.% PrC2 has been studied between 1200–2200° C. Parabolic growth of the oxide layer has been observed for both HfC and HfC-TaC over the entire temperature range. A break in the temperature dependence of the oxidation kinetics occurs around 1600°C. At lower temperatures, the kinetics are limited by gaseous diffusion via pores in the oxide. Above 1800°C, gaseous diffusion through pores becomes less important as scale-growth kinetics are dominated by bulk (ambipolar) diffusion of oxygen and electrons through the oxide.  相似文献   
40.
Computing scattering rates of electrons and phonons stands at the core of studies of electron transport properties. In the high field regime, the interactions between all electron bands with all phonon bands need to be considered. This full band interaction implies a huge computational burden in calculating scattering rates. In this study, a new accelerated algorithm is presented for this task, which speeds up the computation by two orders of magnitude (100 times) and dramatically simplifies the coding. At the same time, it visually demonstrates the physical process of scattering more clearly.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号